Ford Warns GOP Tax Reform Could Hinder EV Battery Plant Operations

Published 1 days agoF

Ford Warns GOP Tax Reform Could Hinder EV Battery Plant Operations

In recent news, Ford has voiced significant concerns about a Republican-led tax reform bill that could negatively impact their electric vehicle battery operations. The legislation seeks to revoke federal production tax credits for EV batteries developed with technology from Chinese entities like Contemporary Amperex Technology Co. Limited (CATL), according to Reuters.

Ford's new $3.5 billion investment in a battery manufacturing facility in Marshall, Michigan, is at stake. The plant plans to employ CATL's technology, and the loss of these federal tax credits could threaten the plant's financial viability. Bill Ford, the company's Executive Chair, stated that the investments were made based on anticipated government incentives, and drastic policy shifts may unfairly challenge their business strategies.

The potential policy changes have broader implications too. The GOP tax plan further proposes speeding up the expiry of tax credits and preventing manufacturing incentives for firms tied to foreign concerns, primarily targeting Chinese companies. This has raised alarms within the clean energy sector, as it risks slowing down a manufacturing boom critical for maintaining U.S. competitiveness in the expanding EV market, as reported by Reuters.

Share this article

Twitter Facebook LinkedIn

Recent Articles

Pfizer and Arvinas Report Positive Trial Results for Breast Cancer Drug

Pfizer and Arvinas Report Positive Trial Results for Breast Cancer Drug

11 minutes agoPFE

Pfizer and Arvinas have announced promising outcomes from their Phase 3 VERITAC-2 trial for vepdegestrant, an experimental breast cancer drug. The trial showed that vepdegestrant effectively delayed disease progression in patients with ESR1 gene mutations, surpassing AstraZeneca's Faslodex. Reuters highlighted that the median progression-free survival for these patients was five months with vepdegestrant, compared to just two months with Faslodex. Additionally, in the broader patient population, vepdegestrant offered a slight improvement in median progression-free survival at 3.8 months, compared to 3.6 months with Faslodex. One key advantage of vepdegestrant noted in the trial is its oral administration, which offers greater convenience than Faslodex's intramuscular injection. Analysts forecast a potential peak in sales reaching $576 million by 2032. Following these successful results, Pfizer and Arvinas are preparing to submit their findings to regulatory authorities worldwide, seeking approval for vepdegestrant. The oral convenience and efficacy of the drug mark a significant advance in treatment options for breast cancer patients, especially those with certain genetic mutations.

Analysts Show Optimism for Southwest Airlines with Revised Ratings

Analysts Show Optimism for Southwest Airlines with Revised Ratings

41 minutes agoLUV

Southwest Airlines has emerged in the spotlight as multiple analysts provide favorable assessments of the company's performance. Raymond James has reaffirmed an "Outperform" rating, albeit with a slight adjustment of the price target to $40.00 from $42.00, suggesting a potential upside nearing 42.76% from the current stock price. This rating comes at a time when many are closely watching the airline sector for signs of recovery and growth. Meanwhile, Morgan Stanley continues to support Southwest with an "Overweight" rating, although it has slightly reduced its price target to $38.00 from $41.00. The firm emphasized Southwest's financial resilience and its disciplined execution of strategic initiatives, asserting confidence in the airline's potential to exceed expectations moving into 2025. Argus Research's recent upgrade of Southwest Airlines from a "Hold" to a "Buy" rating, along with a price target of $35.00, underscores strong travel demand and the airline's proactive growth initiatives as key factors. These analyst ratings collectively signal an encouraging outlook on Southwest Airlines' strategic and operational trajectory. While price targets have been adjusted, the show's overall sentiment is that of confidence in the airline's market position and capability to leverage travel industry dynamics effectively. Reuters also noted the emphasis on Southwest's robust financial and strategic frameworks as central themes among these assessments.

TD Cowen Lowers Marvell Technology's Price Target to $60

TD Cowen Lowers Marvell Technology's Price Target to $60

56 minutes agoMRVL

TD Cowen has recently adjusted its price target for Marvell Technology Inc. to $60, down from a previous target of $95. This change reflects shifts in the evaluation of Marvell's market performance and potential by TD Cowen's analysts. The adjustment was made by TD Cowen's analyst, Joshua Buchalter, who pointed to a challenging market environment with limited upside potential as the primary reason for the revision. Despite the decrease, Buchalter maintains confidence in Marvell's strategic direction, supported by the company's ability to perform strongly even in a difficult sector climate, as reported by Investing.com. Marvell Technology remains focused on exceeding its Fiscal Year 2025 AI targets, demonstrating resilience and effective execution of its plans. While the revised price target highlights immediate market concerns, TD Cowen continues to hold a positive outlook on Marvell's long-term growth, particularly as demand for 5G technology expands.

Engine Capital Halts Activist Campaign as Lyft Aligns with Share Buyback Plan

Engine Capital Halts Activist Campaign as Lyft Aligns with Share Buyback Plan

1 hours agoLYFT

Activist investor Engine Capital, which holds about 1% of Lyft's shares, has ceased its campaign to influence the company after a successful push for strategic changes. The campaign began with Engine Capital nominating two independent directors, Alan L. Bazaar and Daniel B. Silvers, to Lyft's board in April 2025, hoping to improve corporate governance and address board composition issues, Reuters reported. Engine Capital had urged Lyft to consider various strategic alternatives, including a potential sale, and criticized the dual-class share structure that offered significant voting power to the company's founders. In an effort to address the company's stock underperformance, Engine Capital proposed a $750 million accelerated share repurchase program. In response to Engine Capital’s proposal, Lyft increased its stock buyback program to the suggested $750 million in May 2025. This alignment with the activist's plan led Engine Capital to end its campaign and withdraw its board nominees, concluding the push for changes at Lyft.